Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 82.05%4.85B | 53.10%7.39B | 1.50%2.67B | 34.43%4.83B | --2.63B | 19.35%3.59B | 20.73%1.74B | 8.20%3.01B | -5.40%1.44B | 111.52%2.78B |
| Operating income | 82.05%4.85B | 53.10%7.39B | 1.50%2.67B | 34.43%4.83B | 2.63B | 19.35%3.59B | 20.73%1.74B | 8.20%3.01B | -5.40%1.44B | 111.52%2.78B |
| Cost of sales | -93.76%-4.21B | -52.19%-6.31B | 2.18%-2.17B | -38.12%-4.15B | ---2.22B | -23.65%-3B | -25.86%-1.43B | -6.46%-2.43B | 8.42%-1.14B | -120.33%-2.28B |
| Operating expenses | -93.76%-4.21B | -52.19%-6.31B | 2.18%-2.17B | -38.12%-4.15B | -2.22B | -23.65%-3B | -25.86%-1.43B | -6.46%-2.43B | 8.42%-1.14B | -120.33%-2.28B |
| Gross profit | 30.44%642.79M | 58.64%1.08B | 21.68%492.79M | 15.61%679.91M | 404.99M | 1.36%588.1M | 1.51%308.36M | 16.13%580.22M | 7.95%303.77M | 78.85%499.61M |
| Selling expenses | -5.14%-37.4M | -59.13%-76.56M | -17.15%-35.57M | 27.15%-48.11M | ---30.36M | -27.80%-66.04M | -32.53%-32.18M | -2.90%-51.68M | 9.80%-24.28M | -116.23%-50.22M |
| Administrative expenses | -14.89%-99.66M | -59.95%-197.07M | -26.57%-86.75M | 8.37%-123.21M | ---68.54M | -9.67%-134.46M | -12.71%-66.32M | 0.83%-122.61M | 5.61%-58.84M | -113.61%-123.63M |
| Research and development expenses | -26.23%-110.53M | -143.51%-232.93M | -46.42%-87.56M | 21.18%-95.66M | ---59.8M | -37.34%-121.35M | -61.02%-57.47M | -29.20%-88.36M | 6.45%-35.69M | -49.73%-68.39M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5.76M | ---5.19M | ---- |
| Impairment and provision | -337.25%-2.61M | 51.69%-643K | 1,020.41%1.1M | ---1.33M | --98K | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -337.25%-2.61M | 51.69%-643K | 1,020.41%1.1M | ---1.33M | --98K | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | -28.19%19.43M | 96.57%38.22M | 364.39%27.06M | 317.64%19.44M | ---10.24M | 493.49%4.66M | 159.16%2.55M | -168.50%-1.18M | -82.88%982K | 134.95%1.73M |
| Operating profit | 32.45%412.03M | 41.43%609.62M | 31.73%311.07M | 59.12%431.04M | 236.14M | -12.79%270.9M | -14.28%154.94M | 19.89%310.64M | 13.16%180.75M | 75.51%259.1M |
| Financing cost | 36.92%-26.81M | 17.31%-73.24M | 13.35%-42.5M | -132.84%-88.58M | ---49.05M | 10.54%-38.04M | 16.24%-20.02M | 39.46%-42.53M | 31.58%-23.9M | -4,159.85%-70.25M |
| Share of profits of associates | ---542K | ---648K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 43.23%384.67M | 56.43%535.73M | 43.55%268.57M | 47.07%342.46M | 187.09M | -13.15%232.86M | -13.98%134.93M | 41.97%268.11M | 25.68%156.86M | 29.37%188.85M |
| Tax | -28.36%-70.97M | -31.41%-85.23M | -54.64%-55.29M | -0.42%-64.86M | ---35.75M | -55.69%-64.58M | -66.04%-43.48M | -20.69%-41.48M | -5.65%-26.19M | -49.13%-34.37M |
| After-tax profit from continuing operations | 47.08%313.71M | 62.28%450.5M | 40.93%213.28M | 64.97%277.61M | 151.34M | -25.75%168.27M | -30.02%91.45M | 46.70%226.63M | 30.65%130.67M | 25.66%154.48M |
| Earning after tax | 47.08%313.71M | 62.28%450.5M | 40.93%213.28M | 64.97%277.61M | 151.34M | -25.75%168.27M | -30.02%91.45M | 46.70%226.63M | 30.65%130.67M | 25.66%154.48M |
| Minority profit | -155.98%-309K | -180.13%-371K | 140.00%552K | 826.00%463K | --230K | -81.48%50K | -5.15%258K | -33.17%270K | -1.81%272K | --404K |
| Profit attributable to shareholders | 47.61%314.02M | 62.69%450.87M | 40.78%212.73M | 64.75%277.14M | 151.11M | -25.68%168.22M | -30.07%91.19M | 46.91%226.36M | 30.74%130.4M | 25.34%154.08M |
| Basic earnings per share | 47.30%0.161 | 62.64%0.2316 | 40.67%0.1093 | 56.48%0.1424 | 0.0777 | -26.02%0.091 | -30.18%0.0495 | 46.95%0.123 | 30.81%0.0709 | 25.30%0.0837 |
| Diluted earnings per share | 42.27%0.1555 | 59.13%0.2266 | 40.67%0.1093 | 58.05%0.1424 | 0.0777 | -26.75%0.0901 | -30.89%0.049 | 48.19%0.123 | 32.52%0.0709 | 24.25%0.083 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.